Francesco Vaia

3.4k total citations · 1 hit paper
32 papers, 704 citations indexed

About

Francesco Vaia is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Francesco Vaia has authored 32 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Francesco Vaia's work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (7 papers) and Herpesvirus Infections and Treatments (7 papers). Francesco Vaia is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (7 papers) and Herpesvirus Infections and Treatments (7 papers). Francesco Vaia collaborates with scholars based in Italy, United States and United Kingdom. Francesco Vaia's co-authors include Enrico Girardi, Andrea Antinori, Emanuele Nicastri, Vincenzo Puro, Valentina Mazzotta, Anna Rosa Garbuglia, Stefania Cicalini, Francesco Vairo, Silvia Pittalis and Emanuela Giombini and has published in prestigious journals such as International Journal of Molecular Sciences, Clinical Microbiology and Infection and Journal of Medical Virology.

In The Last Decade

Francesco Vaia

31 papers receiving 689 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022

2022 360 citations Andrea Antinori, Valentina Mazzotta et al. profile →

Peers

Countries citing papers authored by Francesco Vaia

Since Specialization

Citations

This map shows the geographic impact of Francesco Vaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Vaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Vaia more than expected).

Fields of papers citing papers by Francesco Vaia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Vaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Vaia. The network helps show where Francesco Vaia may publish in the future.

Co-authorship network of co-authors of Francesco Vaia

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Vaia. A scholar is included among the top collaborators of Francesco Vaia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Vaia. Francesco Vaia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nutrition, Physical Activity and Smoking Habit in the Italian General Adult Population: CUORE Project Health Examination Survey 2018–2019 2024 ·Healthcare ·Chiara Donfrancesco, Brigitta Buttari, (unknown), Sabina Sieri, Anna Di Lonardo, Cinzia Lo Noce, Elisabetta Profumo, Francesca Vespasiano, Claudia Agnoli, Serena Vannucchi, Marco Silano, Daniela Galeone, (unknown), Francesco Vaia, Luigi Palmieri	6
2	Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 2023 ·International Journal of Molecular Sciences ·Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Lavinia Fabeni, Valentina Mazzotta, Simone Lanini, Angela Corpolongo, Anna Rosa Garbuglia, Emanuele Nicastri, Enrico Girardi, Francesco Vaia, Andrea Antinori, Fabrizio Maggi	4
3	Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients 2023 ·Vaccines ·Claudia Minosse, Giulia Matusali, Silvia Meschi, Germana Grassi, Massimo Francalancia, Gianpiero D’Offizi, Pietro Giorgio Spezia, Anna Rosa Garbuglia, Marzia Montalbano, Daniele Focosi, Enrico Girardi, Francesco Vaia, Giuseppe Maria Ettorre, Fabrizio Maggi	3
4	Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients 2023 ·Biomolecules ·Cesare Ernesto Maria Gruber, (unknown), Martina Rueca, Valentina Mazzotta, Giulia Gramigna, Alessandra Vergori, Lavinia Fabeni, Giulia Berno, Emanuela Giombini, Ornella Butera, Daniele Focosi, Ingrid G. Prandi, Giovanni Chillemi, Emanuele Nicastri, Francesco Vaia, Enrico Girardi, Andrea Antinori, Fabrizio Maggi	1
5	What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis 2023 ·Health and Quality of Life Outcomes ·Ilaria Mastrorosa, (unknown), Carmela Pinnetti, Patrizia Lorenzini, Alessandra Vergori, (unknown), Marta Camici, Valentina Mazzotta, Francesco Baldini, Pierangelo Chinello, Paola Mencarini, Maria Letizia Giancola, Amina Abdeddaim, Enrico Girardi, Francesco Vaia, Andrea Antinori	16
6	Pharmacokinetics of tecovirimat in subjects with Mpox 2023 ·International Journal of Antimicrobial Agents ·Massimo Tempestilli, Annalisa Mondi, Antonio D’Avolio, Olindo Forini, Carmela Pinnetti, Valentina Mazzotta, Roberta Gagliardini, Alessia Beccacece, Amedeo De Nicolò, (unknown), Eleonora Cimini, Fabrizio Maggi, Enrico Girardi, Emanuele Nicastri, Marta Boffito, Francesco Vaia, Andrea Antinori	3
7	The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown 2023 ·International Journal of Infectious Diseases ·Francesco Vairo, Sara Leone, Valentina Mazzotta, Pierluca Piselli, Gabriella De Carli, Simone Lanini, Fabrizio Maggi, Emanuele Nicastri, Roberta Gagliardini, Serena Vita, Andrea Siddu, Giovanni Rezza, Alessandra Barca, Francesco Vaia, Andrea Antinori, Enrico Girardi	14
8	Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak 2023 ·Journal of Medical Virology ·Francesca Colavita, Giulia Matusali, Valentina Mazzotta, Aurora Bettini, Daniele Lapa, Silvia Meschi, Massimo Francalancia, Carmela Pinnetti, Licia Bordi, (unknown), Sabrina Coen, Enrico Girardi, Francesco Vaia, Emanuele Nicastri, Andrea Antinori, Fabrizio Maggi	12
9	Kinetics of TTV Loads in Peripheral Blood Mononuclear Cells of Early Treated Acute HIV Infections 2023 ·Viruses ·Isabella Abbate, Gabriella Rozera, Eleonora Cimini, Fabrizio Carletti, Eleonora Tartaglia, (unknown), Silvia Pittalis, Rozenn Esvan, Roberta Gagliardini, Annalisa Mondi, Valentina Mazzotta, Marta Camici, Enrico Girardi, Francesco Vaia, Vincenzo Puro, Andrea Antinori, Fabrizio Maggi	4
10	Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV 2023 ·International Journal of Infectious Diseases ·Alessandra Vergori, Giulia Matusali, Alessandro Cozzi Lepri, Eleonora Cimini, Marisa Fusto, Francesca Colavita, Roberta Gagliardini, Stefania Notari, Valentina Mazzotta, Davide Mariotti, Stefania Cicalini, Enrico Girardi, Francesco Vaia, Fabrizio Maggi, Andrea Antinori	12
11	A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection 2023 ·Pathogens ·(unknown), Annalisa Mondi, Carmela Pinnetti, Valentina Mazzotta, Fabrizio Carletti, Giulia Matusali, Donatella Vincenti, Roberta Gagliardini, (unknown), Carla Fontana, Fabrizio Maggi, Enrico Girardi, Francesco Vaia, Andrea Antinori	3
12	Autopsies Revealed Pathological Features of COVID-19 in Unvaccinated vs. Vaccinated Patients 2023 ·Biomedicines ·Daniele Colombo, Franca Del Nonno, Luisa Marchioni, Eleonora Lalle, Paola Gallì, Francesco Vaia, Laura Falasca	2
13	Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up 2022 ·Viruses ·Giulia Matusali, Giuseppe Sberna, Silvia Meschi, Giulia Gramigna, Francesca Colavita, Daniele Lapa, Massimo Francalancia, Aurora Bettini, Maria Rosaria Capobianchi, Vincenzo Puro, Concetta Castilletti, Francesco Vaia, Licia Bordi	15
14	Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy 2022 ·Viruses ·Francesca Colavita, Alessandra Oliva, (unknown), Andrea Antinori, Enrico Girardi, Concetta Castilletti, Francesco Vaia, Giuseppina Liuzzi	4
15	Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases 2022 ·International Journal of Infectious Diseases ·Linda Petrone, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, Alessandra Aiello, Bruno Laganà, Gilda Cuzzi, Valentina Vanini, Gina Gualano, Alba Grifoni, (unknown), Concetta Castilletti, Silvia Meschi, Francesco Vaia, Emanuele Nicastri, Alessandro Sette, Delia Goletti	21
16	SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH 2022 ·Viruses ·Alessandra Vergori, Alessandro Cozzi‐Lepri, Giulia Matusali, Francesca Colavita, Stefania Cicalini, Paola Gallì, Anna Rosa Garbuglia, Marisa Fusto, Vincenzo Puro, Fabrizio Maggi, Enrico Girardi, Francesco Vaia, Andrea Antinori	18
17	A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19 2022 ·EClinicalMedicine ·Emanuele Nicastri, Franco Marinangeli, Emanuele Pivetta, Elena Torri, Francesco Reggiani, Giuseppe Fiorentino, Laura Scorzolini, Serena Vettori, (unknown), Elizabeth M. Gavioli, Andrea R. Beccari, (unknown), Maria De Pizzol, (unknown), Flavio Mantelli, Francesco Vaia, Marcello Allegretti	17
18	COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020 2021 ·Biomolecules ·Francesca Colavita, Francesco Vairo, Silvia Meschi, Maria Beatrice Valli, Eleonora Lalle, Concetta Castilletti, Danilo Fusco, (unknown), (unknown), (unknown), Maurizio Sanguinetti, Antonino Di, Francesco Vaia, Giuseppe Ippolito, Maria Rosaria Capobianchi	21
19	Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients 2021 ·Liver International ·Gianpiero D’Offizi, Chiara Agrati, Ubaldo Visco‐Comandini, Concetta Castilletti, Vincenzo Puro, Paola Piccolo, Marzia Montalbano, Silvia Meschi, Eleonora Tartaglia, (unknown), Sara Leone, Daniele Lapa, Germana Grassi, Delia Goletti, Giuseppe Ippolito, Francesco Vaia, Giuseppe Maria Ettorre, Raffaella Lionetti	30
20	Efficacy of anti-retraction devices in preventing bacterial contamination of dental unit water lines 2003 ·Journal of Dentistry ·Francesca Berlutti, Luca Testarelli, Francesco Vaia, Massimo De Luca, Giovanni Dolci	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact